Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 18627948422 |
E-mail: | sale@hdimpurity.com |
QQ: | 3001016691 |
Skype: | Chat Now! |
Address: | Biwangxin Technology Building 503, Biwangxin High-tech Industrial Park, Xili Street, Nanshan District, Shenzhen |
ShenZhen H&D Pharmaceutical Technology Co., LTD is a professional supplier of pharmaceutical impurity control products. Short product delivery time, covering more than 90% of cutting-edge generic drug projects; All products must be checked for LCMS and HPLC within one year. We offer custom synthesis and preparation of small molecule compounds.
The company has its own research and development center, focusing on providing pharmaceutical research and development units with new drug and generic drug registration and application of chemical products, including drug standards, drug impurity reference products, characteristic intermediates, analytical testing and custom compound synthesis services. Our delivery standard is not less than 98% purity (HPLC).
The company focuses on providing pharmaceutical research and development units with new drug and generic drug registration applications and chemical products, including drug impurity reference products, standards, pharmaceutical intermediates, as well as drug impurity preparation, separation and purification business.
|
Product Name | MF | CAS | Details |
---|
Avibactam Impurity U | C7H12N3NaO6S | 1797133-98-2 | Details |
Tacrolimus Impurity 30 | Details |
Tacrolimus EP Impurity G | C44H69NO12 | 144490-63-1 | Details |
Tacrolimus EP Impurity C | Details |
Tacrolimus EP Impurity D | C44H69NO12 | 129212-35-7 | Details |
Clindamycin phosphate Impurity N | C18H34ClN2O9PS | 1228573-90-7 | Details |
Tacrolimus Diene | C44H67NO11 | 104987-16-8 | Details |
Clindamycin phosphate EP Impurity E(Hydrochloride) | C18H34Cl2N2O5S | 21462-39-5 | Details |
Tacrolimus EP Impurity A | C43H69NO12 | 104987-12-4 | Details |
Tacrolimus Impurity 36 | C44H69NO12 | 131944-48-4 | Details |
Clindamycin phosphate EP Impurity A | C18H34N2O6S | Details |
Tacrolimus Impurity 27 | C44H69NO12 | Details |
Tacrolimus Impurity 28 | Details |
Clindamycin Phosphate Impurity P | Details |
Landiolol Impurity 44(Dihydrochloride) | Details |
Eravacycline Impurity 9 | C9H11FN6O4 | Details |
Eravacycline Impurity 12 | C9H10F2N6O4 | Details |
Clindamycin phosphate Impurity K | Details |
Clindamycin phosphate EP Impurity D | C18H34ClN2O8PS | 54887-30-8 | Details |
Tacrolimus Impurity 38 | C43H69NO11 | Details |
(E)-3-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2-methylacrylaldehyde | C11H18O3 | 109466-74-2 | Details |
Clindamycin phosphate EP Impurity G | C18H33ClN2O5S | 1440605-46-8 | Details |
Tacrolimus EP Impurity B | Details |
Tacrolimus EP Impurity F | C44H69NO12 | 1393890-33-9 | Details |
Clindamycin Phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
Tacrolimus EP Impurity E | C44H71NO12 | 104987-30-6 | Details |
Clindamycin phosphate EP Impurity H | Details |
Clindamycin Phosphate Impurity O | Details |
Clindamycin phosphate EP Impurity F | C18H35N2O9PS | 27480-30-4 | Details |
Tacrolimus | C44H69NO12 | 104987-11-3 | Details |
Cenobamate Impurity 7 | C8H5Br2ClO | 1261775-99-8 | Details |
Carbidopa Impurity 17 | Details |
Carbidopa EP Impurity J | C10H13BrN2O4 | 43197-33-7 | Details |
Cenobamate Impurity 5 | C10H10ClN5O2 | 913089-08-4 | Details |
Cenobamate Impurity 6 | C10H10ClN5O2 | 913089-09-5 | Details |
Eravacycline Impurity 4 | C11H17NO2 | Details |
Cenobamate Impurity 4 | C10H10ClN5O2 | 913088-45-6 | Details |
Eravacycline Impurity 8 | C13H19NO3 | Details |
Landiolol impurity X | C25H40ClN3O8 | 1253907-85-5 | Details |
Tacrolimus Impurity 33 | C45H71NO12 | Details |
Eravacycline Impurity 3 | C13H18ClN5O | Details |
Eravacycline Dihydrochloride | C27H32ClFN4O8 | 1334714-66-7 | Details |
Eravacycline Impurity 6 | C16H23NO4 | Details |
N-Nitroso Desmethyl Eravacycline | Details |
Eravacycline Impurity 7 | C13H19NO3S | Details |
Carbidopa | C10H14N2O4 | 28860-95-9 | Details |
Eravacycline Impurity 10 | C9H12FN3O4 | Details |
Eravacycline Impurity 11 | C9H11FN6O4 | Details |
Cenobamate Impurity 2 | C9H7ClN4O | 1259059-68-1 | Details |
Tacrolimus Impurity 35 | C43H67NO12 | Details |
Tacrolimus Impurity 39 | Details |
Tacrolimus Impurity 32 | Details |
Tacrolimus Impurity 34 | C44H69NO11 | Details |
Eravacycline Impurity 5 | C18H21NO3 | Details |
Eravacycline Impurity 1 | C11H16ClNO | Details |
Tacrolimus Impurity 31 | C43H69NO11 | Details |
Tacrolimus Impurity 37 | C43H67NO12 | Details |
Cenobamate Impurity 3 | C9H9ClN4O | 2857969-41-4 | Details |
Eravacycline Impurity 1(Tartrate Salt) | Details |
Eravacycline Impurity 13 | Details |
Cenobamate | C22H38N2 | Details |
Cenobamate Impurity 1 | C9H9ClN4O | 1259059-77-2 | Details |
N-Nitroso Niraparib | Details |
Carebastine Impurity 2 | Details |
Imrecoxib Photodegradable Impurity 3 | Details |
Baricitinib Impurity 7 | Details |
Lumateperone Impurity 39 | C14H17BrN2O2 | 2306249-85-2 | Details |
1-Cyclopentyl-4-nitrosopiperazine | C9H17N3O | 61379-66-6 | Details |
Lumateperone Impurity 1 | C24H30FN3O | 1469343-42-7 | Details |
Pitavastatin Impurity 97 | Details |
Carebastine Impurity 1 | C25H28N8O9S2 | Details |
Lumateperone Impurity 42 | Details |
Baricitinib Impurity 12 | C13H15N5O | 1911644-33-1 | Details |
Baricitinib Impurity G | C15H15N7O2S | 2964606-44-6 | Details |
Pitavastatin Impurity 23 | C28H28FNO4 | Details |
Baricitinib Impurity 6 | C16H17N7O2S | 2514763-82-5 | Details |
Pitavastatin Impurity 24 | C13H11NO | Details |
Dotinurad Impurity 3 | C14H9ClFNO4S | Details |
Dotinurad Impurity 8 | C15H11ClINO4S | Details |
Lumepirone Toluenesulfonate Impurity 8 | 2762307-17-3 | Details |
Baricitinib Impurity 8 | Details |
Lumateperone Impurity 43 | Details |
Dotinurad | C14H9Cl2NO4S | 1285572-51-1 | Details |
(2,3,5-triiodophenyl)methanol | C7H5I3O | 31075-53-3 | Details |
Lumateperone Impurity 26 | C24H28FN3O | 1576240-15-7 | Details |
Baricitinib Impurity 17 | C16H18N6O4S | 2271228-52-3 | Details |
Lumateperone Impurity 38 | Details |
Lumateperone | C24H28FN3O | 313368-91-1 | Details |
Lumateperone Impurity 2 | C23H26FN3O | 313368-82-0 | Details |
Baricitinib Impurity 3 | C16H19N7O3S | 2271228-51-2 | Details |
Lumepirone Toluenesulfonate Impurity 11 | C17H21BrN2O4 | 2306249-78-3 | Details |
Lumateperone Impurity 21 | C17H22BrN3O3 | 2098497-32-4 | Details |
1-(4-fluorophenyl)-4-((6bR,10aR)-2-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[3,2,1-ij]quinazolin-8(9H)-yl)butan-1-one | C24H28FN3O | 1576240-16-8 | Details |
Baricitinib Impurity 5 | C17H19N7O3S | 1187595-89-6 | Details |
N-Nitroso Norfloxacin | C16H17FN4O4 | 74011-53-3 | Details |
N-Nitroso Cinacalcet | C22H21F3N2O | 3036581-83-3 | Details |
Lumateperone Impurity 14 | C14H17BrN2O2 | 1059630-08-8 | Details |
Landiolol impurity K | C15H20O5 | 2180628-04-8 | Details |
Eravacycline | C27H31FN4O8 | 1207283-85-9 | Details |
Dotinurad Impurity 14 | C14H9Cl2NO3S | 1285572-55-5 | Details |
Product Total: Product Page: | ||||
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 |